Factors associated with neonatal deaths in very low birth weight infants

1987 ◽  
Vol 156 (7) ◽  
Author(s):  
T. A. Clarke ◽  
P. J. McKenna ◽  
T. G. Matthews
PEDIATRICS ◽  
1986 ◽  
Vol 78 (6) ◽  
pp. 1143-1145
Author(s):  
MYRON E. WEGMAN

About one tenth of all infant deaths occur in babies weighing less than 500 g at birth, almost all of whom die very shortly thereafter. In 1983, when the United States reported 3,638,933 live births, 4,368 of them were less than 500 g; that year there were 26,507 neonatal deaths. This means that slightly more than 0.1% of all live births contributed to 17% of neonatal mortality. Given this order of magnitude, any change in the numbers relating to these tiny babies can have a disproportionate influence on reported infant mortality and on interstate comparisons. Two questions promptly arise. How accurate and meaningful are the data regarding babies born weighing less than 500 g? What can be done to decrease the deaths in this category? Wilson et al1 call attention to how the number of very low birth weight infants reported by a state may be affected by the state's definition of a live birth.


2009 ◽  
Vol 40 (05) ◽  
pp. 224-227 ◽  
Author(s):  
M. M. Vela-Huerta ◽  
M. Amador-Licona ◽  
N. Medina-Ovando ◽  
C. Aldana-Valenzuela

PEDIATRICS ◽  
1996 ◽  
Vol 98 (6) ◽  
pp. A30-A30

Purpose. Cryotherapy for retinopathy of prematurity (ROP) is effective in reducing the incidence of blindness in premature infants. However, macular complications associated with successful treatment have not yet been well studied. Methods. Eighteen very low birth weight (<1251 g) infants (32 eyes) who received cryotherapy for ROP were examined serially for regression of disease and for development of macular abnormalities. Patient characteristics and treatment factors were evaluated to identify risk factors associated with the development of macular abnormalities after successful cryotherapy. Results. Eleven of 32 eyes (34.4%) that had undergone cryotherapy developed significant macular abnormalities, including macular coloboma-like change (six eyes), macular hyperpigmentation (two eyes), irregularly mottled macular hyperpigmentation and hypopigmentation (two eyes), and macular hyperpigmentation and hypopigmentation with subretinal proliferation (one eye). Corrected visual acuity in affected eyes ranged from 0.15 to 0.03 (20/133 to 20/666) compared with 1.0 to 0.2 (20/20 to 20/100) in treated eyes without macular abnormality (P = .0002). No difference in gestational age was noted between infants who did or did not develop macular coloboma-like lesions or pigment abnormalities. Eyes with macular abnormality had more posterior disease (P = .037) and received significantly more cryotherapy than did eyes without macular abnormality (P = .0005). Conclusions. In very low birth weight infants receiving cryotherapy for ROP, development of macular coloboma-like lesions and macular pigment abnormalities were related to greater severity of ROP and a greater amount of cryotherapy. Macular abnormalities were associated with markedly worse visual outcomes than were treated eyes without macular abnormality.


2019 ◽  
Vol 210 ◽  
pp. 91-98.e1 ◽  
Author(s):  
Susan R. Hintz ◽  
Jeffrey B. Gould ◽  
Mihoko V. Bennett ◽  
Tianyao Lu ◽  
Erika E. Gray ◽  
...  

2017 ◽  
Vol 64 (6) ◽  
pp. 495-500
Author(s):  
Gaurav Patwardhan ◽  
Ankit Soni ◽  
Nitin Rachwani ◽  
Sandeep Kadam ◽  
Sanjay Patole ◽  
...  

2007 ◽  
Vol 53 (3) ◽  
pp. 153-157 ◽  
Author(s):  
F. B. de Mello ◽  
M. F. B. de Almeida ◽  
A. M. N. dos Santos ◽  
H. de Paula Fiod Costa ◽  
M. H. Miyoshi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document